2008 Clinical Practice Guidelines - Canadian Diabetes Association

2008 CLINICAL PRACTICE GUIDELINES
S12
Table 4. Definitions of the metabolic syndrome
Diagnostic
criteria
WHO (13) NCEP ATP III
2001 (14) 2004 (15)
Diabetes, IFG, IGT or
insulin resistance (assessed
by clamp studies) plus ≥2
other risk determinants
are present
BG Diabetes, IFG, IGT or
insulin resistance
OTHER RELEVANT GUIDELINES
Screening for Type 1 and Type 2 Diabetes, p. S14
Prevention of Diabetes, p. S17
Type 1 Diabetes in Children and Adolescents, p. S150
Type 2 Diabetes in Children and Adolescents, p. S162
RELEVANT APPENDIX
Appendix 1. Etiologic Classification of Diabetes Mellitus
IDF (16)
≥3 risk determinants are present Central obesity (using ethnic-specific values)
plus ≥2 other risk determinants are present
(if BMI is >30 kg/m 2 , central obesity can be
assumed and WC does not need to be
measured)
FPG ≥6.1 mmol/L FPG ≥5.6 mmol/L FPG ≥5.6 mmol/L (or previously diagnosed
type 2 diabetes)
BP ≥140/90 mm Hg ≥130/85 mm Hg ≥130/85 mm Hg (or receiving treatment for
previously diagnosed hypertension)
TG ≥1.7 mmol/L ≥1.7 mmol/L ≥1.7 mmol/L (or receiving treatment)
HDL-C 0.85 (women)
Urinary albumin excretion
rate >20 µg/min
or
ACR ≥30 mg/g
ACR = albumin to creatinine ratio
BG = blood glucose
BMI = body mass index
BP = blood pressure
FPG = fasting plasma glucose
HDL-C = high-density lipoprotein cholesterol
IDF = International Diabetes Federation
IFG = impaired fasting glucose
IGT = impaired glucose tolerance
88 cm (women)
NA NA